<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This is a retrospective study based on a population of 80 patients with <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue diseases</z:e> from the University Hospital of Puerto Rico </plain></SENT>
<SENT sid="1" pm="."><plain>Among the population, 62 (77.5%) of the patients had <z:hpo ids='HP_0002725'>Systemic Lupus Erythematosus</z:hpo> (SLE), whom we were most interested to monitor </plain></SENT>
<SENT sid="2" pm="."><plain>The investigation revealed an incidence of 13.8% of anthiophospholipid syndrone within the general population </plain></SENT>
<SENT sid="3" pm="."><plain>Among the patients with SLE it was 12.9%, and only 5.5% among the population with other diagnoses </plain></SENT>
<SENT sid="4" pm="."><plain>The antibody found with the highest frequency within the <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> population was the anticardiolipin IgG (30.6%) and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (17.7%) </plain></SENT>
<SENT sid="5" pm="."><plain>The antibody frequency among patients with other diagnoses was only 5.5% for <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and 5.5% for anticardiolipin IgM (the only one found) </plain></SENT>
<SENT sid="6" pm="."><plain>Among SLE's clinical manifestations, the most frequently found were thrombocitopenia and <z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">pregnancy complications</z:e> </plain></SENT>
</text></document>